NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

DNA解讀、合成、編輯全球市場

Global DNA Read, Write and Edit Market

出版商 BCC Research 商品編碼 910879
出版日期 內容資訊 英文 399 Pages
訂單完成後即時交付
價格
DNA解讀、合成、編輯全球市場 Global DNA Read, Write and Edit Market
出版日期: 2019年09月06日內容資訊: 英文 399 Pages
簡介

全球DNA解讀、合成、編輯應用市場,預估將從2019年的170億美元於2024年成長至431億美元規模,期間將以20.5%的CAGR (複合年均增長率) 成長。

本報告研究全球DNA解讀、合成、編輯市場,分析彙整全球市場概要和趨勢、定序技術、市場應用、產業結構、重要臨床定序創製、醫藥品、生物科技企業創新、幹細胞療法和基因治療的研發計畫、主要企業等情報。

第1章 前言

第2章 摘要重點

第3章 概要

  • DNA解讀、合成、編輯技術與市場
  • 大型創製和聯盟
  • DNA解讀、合成、編輯技術的應用
  • 全球DNA解讀、合成、編輯市場

第4章 技術背景

  • 核酸技術簡介
  • 遺傳異變和分析
  • 定序技術
  • Sanger定序
  • 次世代定序
  • DNA合成技術
  • 基因編輯技術
  • 基因編輯傳輸技術
  • 病毒傳輸技術

第5章 DNA解讀、合成、編輯創製

第6章 DNA解讀、合成、編輯應用

  • 應用概要
  • 基因組編輯應用
  • DNA定序應用
  • DNA合成應用
  • DNA編輯應用

第7章 DNA解讀、合成、編輯產業

  • 定序產業
  • 長片段定序產業
  • DNA合成產業
  • DNA編輯產業

第8章 收購和策略聯盟

第9章 DNA解讀、合成、編輯市場

  • 成長推動因素
  • 全球DNA解讀 (定序) 、合成、編輯 (基因編輯) 市場
  • 臨床診斷定序市場
  • DNA合成市場
  • 基因編輯市場

第10章 專利

  • 循環腫瘤細胞專利
  • Exosome專利
  • Cell-free DNA專利
  • 定序相關專利課題
  • 基因編輯相關專利
  • 基因編輯專利 (Sangamo案例研討)
  • RNA治療相關專利

第11章 核酸解讀、合成、編輯企業簡介

目錄
Product Code: BIO193A

Report Highlights:

The global market for DNA read, write and edit applications should grow from $17.0 billion in 2019 to $43.1 billion by 2024 with a compound annual growth rate (CAGR) of 20.5% during the period of 2019-2024.

The global market for DNA read (sequencing) applications should grow from $12.4 billion in 2019 to $28.5 billion by 2024 with a CAGR of 18.1% during the period of 2019-2024.

The global market for gene editing applications should grow from $1.3 billion in 2019 to $6.8 billion by 2024 with a CAGR of 39.1% during the period of 2019-2024.

Report Scope:

The scope of the report includes DNA read, write and edit technologies, applications, industries, initiatives, patents and companies. The markets for read, write and edit products and services are given for 2017, 2018, 2019 (estimated) and 2024 (forecast).

This report reviews the main read, write and edit technologies and explains why genetic variation is important in clinical testing and disease. It then discusses significant large-scale research initiatives that impact read, write and edit applications. Of particular interest is a discussion of population-scale sequencing projects throughout the world, and their likely impact. The main market driving forces for read, write and edit products and services are listed and discussed.

The report quantifies each of the main market segments. The read (sequencing) market is quantified by delivered format, including sequencing workflow products (sample preparation kits and reagents, sequencing instruments and consumables, and informatics) and sequencing services (clinical diagnostics and sequencing services to applied market customers).

The sequencing workflow products market is quantified by type, that is, DNA isolation and extraction; target enrichment; library preparation; and informatics/ecosystems. The sequencing instruments and consumables market is given by platform (Sanger, NGS and 3GS).

The sequencing services market is analyzed by end user application (applied, clinical, and R&D). Within sequencing services, the applied market is analyzed by end-user application (agriculture, biopharma, consumer, microbiology, population-scale genomics, synthetic biology and other).

Also within sequencing services, the clinical market is analyzed and quantified by disease category (cardiovascular, clinical microbiology and infectious diseases, Mendelian disorders, metabolic/immune disorders, neurology, oncology, reproductive health and transplant medicine).

The DNA write (synthesis) market is quantified by product type (oligonucleotides, synthetic biology parts, genes and RNA therapeutics). The oligonucleotide market is analyzed by application (gene editing, sequencing, PCR, FISH, microarray, gene synthesis and other). The gene market is quantified by gene type (standardized, value-added). Finally, the RNA therapeutics market is quantified by platform (RNA interference, antisense oligos, micro RNA modulation and mRNA) and by disease category (cancer, hematology, musculoskeletal, neurology and rare diseases).

The DNA edit (gene editing) market is quantified by application (agriculture, biopharma, diagnostics and therapeutics); editing platform (CRISPR, meganuclease, TALEN, ZFN). The gene editing agriculture market is analyzed by product type (crop/seeds, livestock). The gene editing biotechnology market is analyzed by product type (kits and reagents, cell line engineering, animal models and services). The gene editing therapeutics market is analyzed by disease category (eye and rare diseases).

Specific geographic markets discussed include North America, Europe, Asia-Pacific, and the rest of the world (ROW).

Industry sectors analyzed include next-generation sequencing; long read sequencing; DNA synthesis; RNA therapies; and gene editing.

More than 320 companies in the read, write and edit industry are profiled in this report.

BCC Research also provides a summary of more than 180 of the main industry acquisitions and strategic alliances that took place from January 2018 through June 2019, including key alliance trends.

Report Includes:

  • 28 data tables and 77 additional tables
  • An overview of the global market for DNA read, write and edit technologies, applications, and industries
  • Analyses of global market trends, with market data from 2017, 2018, estimates for 2019, and projections of compound annual growth rates (CAGRs) through 2024
  • Discussion on sequencing technologies, market applications, industry structure, and important clinical sequencing initiatives
  • Information pertaining to several significant large-scale research initiatives that are contributing to sequencing services, write synthesis and gene editing technologies' market development
  • A look at the innovations in pharmaceutical and biotechnology companies and research & development programs in stem cell-based therapies and gene therapies
  • Coverage of significant patents and their allotments in each category, as well as major industry acquisitions and strategic alliances data
  • Company profiles of over 320 major global players within the industry, including 3Billion Inc., 23Andme Inc., Bayer AG, Becton, Dickinson and Co. (BD), Bio-Rad Laboratories, Pacific Biosciences, Qiagen NV, Roche Holding AG and Thermo Fisher Scientific Inc.

Table of Contents

Chapter 1: Introduction

  • Study Goals and Objectives
  • Reasons for Doing the Study
  • Scope of Report
  • Methodology
  • Information Sources
  • Geographical Breakdown
  • Analyst's Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2: Summary and Highlights

Chapter 3: Overview

  • DNA Read, Write and Edit Technologies and Markets
  • Large-Scale Initiatives and Consortia
  • Applications of DNA Read, Write and Edit Technologies
    • DNA Read, Write and Edit Market Driving Forces
  • Global DNA Read, Write and Edit Markets

Chapter 4: Technology Background

  • Introduction to Nucleic Acid Technologies
  • Genetic Variation and Analysis
  • Sequencing Technologies
  • Sanger Sequencing
  • Next-generation Sequencing
  • DNA Write (Synthesis) Technologies
    • PCR-Based Approaches
    • Solid-Phase-Based Approaches
    • Microfluidic Technologies
  • Gene Editing Technologies
    • CRISPR Enzyme Technologies
  • Gene Editing Delivery Technologies
  • Viral Delivery Technologies
    • Non-Viral Delivery Technologies

Chapter 5: DNA Read, Write and Edit Initiatives

  • Initiatives
  • American Gut Consortium
  • BabySeq
  • Blood Profiling Atlas
  • Cancer-ID
  • Cancer Moon Shots Program
  • China Precision Medicine Initiative
  • Clinical Genome Resource
  • Epigenetics for Females Personalized Cancer Care
  • France Genomic Medicine Plan
  • Friends of Cancer Research Project
  • Gene Therapy Initiative
  • Human Cell Atlas Consortium
  • Immunomonitor Consortium
  • Integration of Imaging and Fluid-based Tumor Monitoring in Cancer Therapy Program
  • Laboratory for Genomics Research
  • Liquid Biopsies and Imaging for Improved Cancer Care
  • Lung Cancer Master Protocol Project
  • Matchmaker Exchange
  • Medical Genome Initiative
  • Metagenomics and Metadesign of Subways and Urban Biomes
  • Million Veteran Program
  • Molecular Integration in Neurological Diagnosis
  • MedSeq
  • National Microbiome Initiative
  • Next-generation Single Cell Analysis Program
  • PreCancer Atlas
  • Precision Medicine Initiative
  • Prospective Registry of Multiple Testing
  • Quality Assurance Initiative Pathology Project
  • Somatic Cell Genome Editing Program
  • Telomere-to-Telomere Consortium
  • Trans Omics for Precision Medicine Initiative
  • Population Sequencing Programs

Chapter 6: DNA Read, Write and Edit Applications

  • Applications Overview
  • Genome Editing Applications
  • DNA Sequencing Applications
    • R&D Applications
    • Applied Applications
  • DNA Write (Synthesis) Applications
    • Oligonucleotides
    • Synthetic Genes
    • BioBrick (Synbio) Parts
  • Genome Editing Applications
    • Cell Engineering
    • Organism Engineering
    • Screening and Tools

Chapter 7: DNA Read, Write and Edit Industries

  • Sequencing Industry
    • Sequencing Instruments Industry
  • Long Read Sequencing Industry
  • DNA Write (Synthesis) Industry
    • Oligos as Therapeutics
    • Gene Synthesis Workflow
    • Gene Synthesis Value Chain
    • Synthetic Gene Market Segments
  • Gene Editing Industry

Chapter 8: Acquisitions and Strategic Alliances

  • Acquisitions
  • Strategic Alliances
    • Key Trends
    • Alliance Summaries

Chapter 9: DNA Read, Write and Edit Markets

  • Industry Growth-Driving Forces
    • DNA Read, Write and Edit Technologies
  • Global DNA Read (Sequencing), Write (Synthesis) and Edit (Gene Edit) Markets
    • DNA Read (Sequencing) Markets
  • Clinical Diagnostic Sequencing Market
    • Cardiology Market
  • DNA Write (Synthesis) Markets
  • Gene Editing Market
    • Market for Gene-edited Crops/Seeds
    • Gene-edited Livestock Market

Chapter 10: Patents

  • Circulating Tumor Cell Patents
  • Exosome Patents
  • Cell-free DNA Patents
  • Sequencing-related Patent Issues
  • Gene Editing-Related Patents
  • Gene Editing Patents (Sangamo Case Study)
  • RNA Therapy-related Patents

Chapter 11: Nucleic Acid Read, Write and Edit Company Profiles

  • 3BILLION INC.
  • 10X GENOMICS INC.
  • 23ANDME INC.
  • ADAPTIVE BIOTECHNOLOGIES INC.
  • ADMERA HEALTH
  • ADVERUM BIOTECHNOLOGIES
  • AGILENT TECHNOLOGIES INC.
  • AJINOMOTO CO., INC.
  • ALCEDIAG
  • ALDEVRON
  • ALLERGAN PLC
  • ALLOGENE THERAPEUTICS INC.
  • ALMAC GROUP LTD.
  • AMARANTUS BIOSCIENCE HOLDINGS INC.
  • AMBRY GENETICS
  • AMFORA INC.
  • ANCHORDX MEDICAL CO., LTD.
  • ANNOROAD GENE TECHNOLOGY CO., LTD.
  • ANSA BIOTECHNOLOGIES INC.
  • APERIOMICS INC.
  • ANGES INC.
  • APEIRON BIOLOGICS AG
  • ARBOR BIOTECHNOLOGIES INC.
  • ARCADIA BIOSCIENCES INC.
  • ARCHER DX
  • ARCTURUS THERAPEUTICS INC.
  • ARUP LABORATORIES
  • ASIA GENOMICS PTE. LTD.
  • ASTRIDBIO TECHNOLOGIES KFT.
  • ASURAGEN INC.
  • ASTRAZENECA PLC
  • ATG BIOSYNTHETICS GMBH
  • ATHENA DIAGNOSTICS INC.
  • ATRECA INC.
  • ATUM
  • AVECIA
  • BASE4 INNOVATION LTD.
  • BASF AG
  • BAYER AG
  • BAYLOR GENETICS
  • BEAM THERAPEUTICS INC.
  • BECTON, DICKINSON AND CO.
  • BENSON HILL BIOSYSTEMS INC.
  • BERRY GENOMICS CO., LTD.
  • BGI SHENZHEN
  • BIOARRAY S.L.
  • BIO BASIC INC.
  • BIOCEPT INC.
  • BIODESIX INC.
  • BIOGEN INC.
  • BIOMARX INC.
  • BIONEER CORP.
  • BIO-RAD LABORATORIES INC.
  • BIO S&T INC.
  • BIO-TECHNE LTD.
  • BLUEBIRD BIO
  • BLUE HERON BIOTECH LLC
  • BLUEPRINT GENETICS
  • BLUESTAR GENOMICS INC.
  • B-MOGEN BIOTECHNOLOGIES INC.
  • BOREAL GENOMICS
  • BRISTOL-MYERS SQUIBB CO.
  • BROOKS LIFE SCIENCES
  • CALYXT INC.
  • CAMBRIDGE EPIGENETIX LTD.
  • CANCER GENETICS
  • CAREDX INC.
  • CARIS LIFE SCIENCES
  • CARIBOU BIOSCIENCES INC.
  • CASEBIA THERAPEUTICS
  • CASZYME
  • CATALOG TECHNOLOGIES INC.
  • CEGAT GMBH
  • CELGENE CORP.
  • CELLECTIS SA
  • CELLMAX LIFE
  • CELSEE INC.
  • CENTOGENE AG
  • CERGENTIS B.V.
  • CHRONIX BIOMEDICAL
  • CIBUS INC.
  • CIRCULOGENE THERANOSTICS
  • CIRCULOMICS INC.
  • COFACTOR GENOMICS INC.
  • COLOR GENOMICS
  • COOPERSURGICAL, INC.
  • CORIELL LIFE SCIENCES INC.
  • COSMOSID
  • CRISPR THERAPEUTICS AG
  • CYGNUS BIOSCIENCES CO., LTD.
  • DANAHER CORP.
  • DARUI BIOTECHNOLOGY CO., LTD.
  • DATAR CANCER GENETICS LTD.
  • DEPIXUS
  • DESKTOP GENETICS LTD.
  • DEVYSER AB
  • DIACARTA INC.
  • DIAGNOMICS
  • DIPLOID
  • DIRECTED GENOMICS LLC
  • DIRECT GENOMICS CO., LTD.
  • DNA ELECTRONICS LTD.
  • DNANEXUS INC.
  • DNA SCRIPT
  • DOVETAIL GENOMICS LLC
  • DOWDUPONT INC.
  • EDIGENE CORP.
  • EDIGENE INC.
  • EDITAS MEDICINE INC.
  • EGENESIS INC.
  • ELECTRONIC BIOSCIENCES
  • ELIGO BIOSCIENCE
  • ENVISION GENOMICS
  • EPIC SCIENCES INC.
  • EPOCH LIFE SCIENCE INC.
  • ESPERITE NV
  • ETAGEN PHARMA
  • EUROFINS SCIENTIFIC
  • EVONETIX
  • EXACT SCIENCES CORP.
  • EXPEDEON AG
  • EZLIFE BIO INC.
  • FABRIC GENOMICS
  • FLUXION BIOSCIENCES INC.
  • FREENOME INC.
  • FRY LABORATORIES LLC
  • FULL GENOMES CORP.
  • FUSION GENOMICS CORP.
  • G+FLAS LIFE SCIENCES INC.
  • GENAPSYS INC.
  • GENCOVE INC.
  • GENDX BV
  • GENE BY GENE LTD.
  • GENEDX INC.
  • GENEMED SYNTHESIS INC.
  • GENERAY BIOTECH CO., LTD.
  • GENETICS RESEARCH LLC
  • GENOMATIX SOFTWARE GMBH
  • GENOME. ONE PTY LTD.
  • GENOMIC EXPRESSION
  • GENOMIC HEALTH INC.
  • GENOME PROFILING LLC
  • GENOMNIA SRL
  • GENOMONCOLOGY
  • GENOSPACE
  • GENOOX
  • GENEXOSOME TECHNOLOGIES INC.
  • GENSCRIPT
  • GENUS PLC
  • GIGAGEN INC.
  • GILEAD SCIENCES INC.
  • GINKGO BIOWORKS
  • GOLDEN HELIX
  • GRAIL INC.
  • GRANDOMICS BIOSCIENCES CO., LTD.
  • GUARDANT HEALTH INC.
  • GUARDIOME
  • HAPLOX BIOTECHNOLOGY
  • HELITEC
  • HELIX OPCO LLC
  • HELIXWORKS TECHNOLOGIES LTD.
  • HISTOGENETICS LLC.
  • HORIZON DISCOVERY GROUP PLC
  • HTG MOLECULAR DIAGNOSTICS INC.
  • HOMOLOGY MEDICINES INC.
  • HUMAN LONGEVITY INC.
  • ILLUMINA INC.
  • INEX INNOVATIONS EXCHANGE PTE. LTD.
  • INIVATA LTD.
  • INSCRIPTA INC.
  • INTELLIA THERAPEUTICS INC.
  • INTERPACE DIAGNOSTICS LLC
  • INVITAE
  • INVIVOSCRIBE INC.
  • IREPERTOIRE INC.
  • KAILOS GENETICS
  • KANEKA EUROGENTEC S.A.
  • KARIUS INC.
  • KELLBENX INC.
  • KEW INC.
  • KINGMED DIAGNOSTICS CENTER CO., LTD.
  • KWS SAAT SE
  • LABGENIUS LTD.
  • LABORATORY CORP. OF AMERICA INC.
  • LABORATORY FOR MOLECULAR MEDICINE
  • LC SCIENCES
  • LGC GROUP
  • LEUCINE RICH BIO PVT. LTD.
  • LEXENT BIO INC.
  • LOCUS BIOSCIENCES
  • LOGICBIO THERAPEUTICS
  • LOOP GENOMICS
  • LUNGLIFE AI, INC.
  • MACROGEN INC.
  • MAPMYGENOME
  • MAYO MEDICAL LABORATORIES
  • MDXHEALTH INC.
  • MEDGENOME LABS PVT. LTD.
  • MENARINI SILICON BIOSYSTEMS SPA
  • MERCK KGAA
  • MICROSOFT CORP.
  • MOGENE LLC
  • MOLECULAR ASSEMBLIES INC.
  • MOLECULAR HEALTH GMBH
  • MOLECULARMD CORP.
  • MOLECULAR LOOP BIOSOLUTIONS LLC
  • MYRIAD GENETICS, INC.
  • N-OF-ONE INC.
  • NANOSTRING TECHNOLOGIES INC.
  • NATERA INC.
  • NAVERIS INC.
  • NEOGENOMICS LABORATORIES
  • NEW ENGLAND BIOLABS
  • NEWGENE LTD.
  • NEW ONCOLOGY GMBH
  • NGENEBIO CO., LTD.
  • NIPD GENETICS
  • NOVARTIS PHARMA AG
  • NOVOGENE CO., LTD.
  • NUCELIS LLC
  • NUCLERA NUCLEICS LTD.
  • NUGEN TECHNOLOGIES INC.
  • NUMEDII
  • NUPROBE INC.
  • NX PRENATAL INC.
  • OCUNEXUS THERAPEUTICS INC.
  • OMEGA BIO-TEK INC.
  • OMNISEQ LLC
  • ONCOCYTE CORP.
  • ONCODNA S.A.
  • ONEOME INC.
  • ONTERA
  • OTHRAM INC.
  • OXFORD BIOMEDICA PLC
  • OXFORD GENETICS LTD.
  • OXFORD NANOPORE TECHNOLOGIES LTD.
  • PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
  • PAIRWISE PLANTS INC.
  • PANGAEA ONCOLOGY
  • PARADIGM DIAGNOSTICS INC.
  • PARSEQ LAB CO., LTD.
  • PATHWAY GENOMICS CORP.
  • PERKINELMER INC.
  • PERSONAL GENOME DIAGNOSTICS INC.
  • PERSONALIS INC.
  • PFIZER INC.
  • PHIO PHARMACEUTICALS CORP.
  • PIERIANDX
  • POPULATION GENETICS TECHNOLOGIES LTD.
  • PORTABLE GENOMICS LLC
  • POSEIDA THERAPEUTICS INC.
  • POSITIVE BIOSCIENCE
  • PRECIPIO INC.
  • PRECISION BIOSCIENCES INC.
  • PREDICINE INC.
  • PRENETICS
  • PREVENTIONGENETICS INC.
  • PROMEGA CORP.
  • Q-STATE BIOSCIENCES
  • QIAGEN NV
  • QUANTAPORE INC.
  • QUANTUM BIOSYSTEMS INC.
  • QUANTUMDX
  • QUEST DIAGNOSTICS INC.
  • RARECYTE INC.
  • REAL-TIME GENOMICS INC.
  • RECOMBINETICS, INC.
  • RESOLUTION BIOSCIENCE INC.
  • ROCHE HOLDING AG
  • SANGAMO THERAPEUTICS INC.
  • SAREPTA THERAPEUTICS INC.
  • SCREENCELL
  • SEEKIN
  • SEQUENCING.COM
  • SEVEN BRIDGES GENOMICS INC.
  • SGI-DNA INC.
  • SHINEGENE MOLECULAR BIO-TECHNOLOGIES INC.
  • SIGMA ALDRICH CORP.
  • SHERLOCK BIOSCIENCES
  • SINGLERA GENOMICS INC.
  • SISTEMAS GENOMICOS SL
  • SOFTGENETICS LLC
  • SOPHIA GENETICS
  • SPERA MEDICAL
  • STA PHARMACEUTICAL CO., LTD.
  • STRAND LIFE SCIENCES PVT. LTD.
  • STRATOS GENOMICS INC.
  • SUPRATECH MICROPATH LABORATORY & RESEARCH INSTITUTE PVT. LTD.
  • SYNBIO TECHNOLOGIES INC.
  • SYAPSE
  • SYNGENTA AG
  • SYNPROMICS LTD.
  • SYNTHEGO CORP.
  • SYNTHETIC GENOMICS INC.
  • TAKARA BIO
  • TEMPUS
  • THERANOSIS LIFE SCIENCES PVT. LTD.
  • THERMO FISHER SCIENTIFIC INC.
  • THRIVE EARLY DETECTION CORP.
  • TOOLGEN
  • TRACE GENOMICS INC.
  • TRANSLATE BIO
  • TROPIC BIOSCIENCES UK LTD.
  • TWIST BIOSCIENCE
  • TWINSTRAND BIOSCIENCES
  • UBIQUITY GENOMICS INC.
  • VELA DIAGNOSTICS
  • VEROGEN INC.
  • VERITAS GENETICS
  • VIR BIOTECHNOLOGY INC.
  • VORTEX BIOSCIENCES
  • XING TECHNOLOGIES LLC
  • YIELD10 BIOSCIENCES INC.
  • YIKON GENOMICS CO., LTD.
  • YOURGENE HEALTH PLC
  • ZHEJIANG DIAN DIAGNOSTICS CO., LTD.

List of Tables

  • Summary Table: Global Market for DNA Read, Write and Edit, by Application, Through 2024
    • Table 1: Report Scope
    • Table 2: Impact of Large-scale Initiatives on the Read, Write and Edit Industry
    • Table 3: Life Cycle Status of Applications for Read, Write and Edit Technologies
    • Table 4: Driving Forces of DNA Read, Write and Edit Industry Growth
    • Table 5: Global Market for DNA Read, Write and Edit, by End User, Through 2024
    • Table 6: Chemical Building Blocks of DNA
    • Table 7: DNA Translation and Transcription
    • Table 8: Long-range DNA Structure
    • Table 9: Genetic Variant Types
    • Table 10: DNA Read, Write and Edit Technology Overview
    • Table 11: Sequencing Technology Development, 1990-2020
    • Table 12: Cost to Sequence a Single Human Genome, 2001-2019
    • Table 13: Sequencing Technology Summary
    • Table 14: Sanger Sequencing Summary
    • Table 15: Sanger Sequencing Improvements
    • Table 16: Advanced Sequencing Technologies
    • Table 17: Roche Next-generation Sequencing Workflow
    • Table 18: Illumina Next-generation Sequencing Workflow
    • Table 19: Thermo Fisher Next-generation Sequencing Workflow
    • Table 20: Comparison of Gene Synthesis Technologies
    • Table 21: Importance of Microfluidics Technologies in Read and Write Applications
    • Table 22: Gene Editing Therapeutic Interventions
    • Table 23: Gene Editing Technology Approaches
    • Table 24: Major Gene Editing Technologies
    • Table 25: Comparison of CRISPR Enzyme Technologies
    • Table 26: Delivery Vector Technical Hurdles
    • Table 27: Comparison of Viral Vector Types
    • Table 28: Non-Viral Delivery Methods
    • Table 29: DNA Read, Write and Edit: R&D Programs
    • Table 30: Population Sequencing Projects
    • Table 31: Summary of Applications for DNA Read, Write and Edit Technologies
    • Table 32: Role of DNA Read and Write Technologies in a Typical CRISPR Gene Editing Experiment
    • Table 33: Sequencing Projects in GOLD Database, 2014-2018
    • Table 34: Percentage Share of All Sequencing Projects in GOLD Database, by Sequencing Strategy, 2018
    • Table 35: Main Sequencing Applications
    • Table 36: Comparison of Genetic Analysis Platforms
    • Table 37: Impact of Sequencing on Agricultural Product Classes
    • Table 38: Key Applications in Forensics/Human Identity Sequencing
    • Table 39: Key Applications in Microbial Sequencing
    • Table 40: Genetic Testing Scope
    • Table 41: Key Applications for Sequencing-based Diagnostics
    • Table 42: Cancer Applications
    • Table 43: Mendelian Disorders Applications
    • Table 44: Reproductive Health Screening Applications
    • Table 45: Ethical Issues Associated with Prenatal and Newborn Screening
    • Table 46: Microbiology and Infectious Disease Applications
    • Table 47: Complex Disorder Applications
    • Table 48: Transplant Diagnostics Application
    • Table 49: Oligonucleotide Applications
    • Table 50: RNA Therapy Segments
    • Table 51: Synthetic Gene Applications
    • Table 52: Gene Editing Applications
    • Table 53: Advanced Sequencing Industry Company Positioning
    • Table 54: End-to-End Sequencing Approaches
    • Table 55: Long-Read Sequencing Industry Players
    • Table 56: Nucleic Acid Synthesis Key Competitor Strategies
    • Table 57: RNA Therapy Segments
    • Table 58: Producers of RNA Therapies
    • Table 59: Gene Synthesis Workflow
    • Table 60: Gene Synthesis Market Factors of Differentiation
    • Table 61: Gene Editing Industry
    • Table 62: Regulatory Situation of Gene-edited Crops, by Country/Region
    • Table 63: DNA Read, Write and Edit Industry Acquisitions, January 2018-June 2019
    • Table 64: DNA Read, Write and Edit Industry Strategic Alliances, January 2018-June 2019
    • Table 65: Driving Forces for Growth in the DNA Read, Write and Edit Industry
    • Table 66: Global DNA Read, Write and Edit Market, by Region, Through 2024
    • Table 67: Global Market for DNA Read Sequencing, by Segment, Through 2024
    • Table 68: Global Market for DNA Sequencing Instruments and Consumables, by Platform Generation, Through 2024
    • Table 69: Global Market for DNA Sequencing Workflow Products, by Product Type, Through 2024
    • Table 70: Global Market for DNA Sequencing Services, by End User, Through 2024
    • Table 71: Global Market for Applied Sequencing Services, by Application, Through 2024
    • Table 72: Driving Forces in the Growth of Synthetic Biology
    • Table 73: Global Market for Clinical Diagnostics Sequencing, by Disease Category, Through 2024
    • Table 74: Examples of Dilated Cardiomyopathy Test Providers
    • Table 75: Microbial Sequencing Landscape
    • Table 76: Multiple Sclerosis Diagnostic Technologies
    • Table 77: Global Market for DNA Write Synthesis, by Product Type, Through 2024
    • Table 78: Global Market for Oligonucleotides, by Application, Through 2024
    • Table 79: Global Market for Synthetic Genes, by Type, Through 2024
    • Table 80: Global Market for RNA Therapeutics, by Platform, Through 2024
    • Table 81: GalNAc-conjugated RNA Therapy Pipeline
    • Table 82: Global Market for RNA Therapeutics, by Disease Category, Through 2024
    • Table 83: Global Market for Gene Editing, by End User, Through 2024
    • Table 84: Global Market for Gene Editing, by Editing Platform, Through 2024
    • Table 85: Global Market for Gene Editing Agriculture, by End Use Application, Through 2024
    • Table 86: Advantages of Gene Editing for Crop Enhancement
    • Table 87: Calyxt Market Potential of Gene-edited Crops
    • Table 88: Commercialization Pathway for Gene-edited Crops
    • Table 89: Global Market for Gene Editing Biotechnology, by Product Type, Through 2024
    • Table 90: Global Market for Gene Editing Therapeutics, by Disease Category, Through 2024
    • Table 91: Gene Editing Clinical Pipeline, 2019
    • Table 92: CTC-related Patents, by Country/Region, 2008-2018
    • Table 93: Exosome-related Patents, by Country/Region, 2008-2018
    • Table 94: cfDNA-related Patents, by Country/Region, 2008-2018
    • Table 95: Status of Liquid Biopsy and Sequencing-related Patent Disputes
    • Table 96: CRISPR-Cas9 Patent Groups
    • Table 97: CRISPR-Cas9 Patent Licensing Fields
    • Table 98: Sangamo's Collaborative Agreements Related to ZFN Technology
    • Table 99: Sangamo Therapeutics' Patent Positions
    • Table 100: RNA Therapy Patents and Patent Applications, by Leading Companies
    • Table 101: 23andMe: Data Generated by Platforms
    • Table 102: Ginkgo Bioworks: Engineered-Organism Workflow
    • Table 103: Homology Medicines: Gene Editing Vs. Gene Therapy Approach
    • Table 104: PGT: Sensitivity to Detect Drug-resistant Mutations in Viruses

List of Figures

  • Summary Figure: Global Market for DNA Read, Write and Edit, by Application, 2017-2024
    • Figure 1: Central Dogma of Molecular Biology
    • Figure 2: Schematic of Conventional DNA Synthesis Technologies
    • Figure 3: Microarrays in DNA Synthesis